Literature DB >> 9842886

CD38+ CD45RB(low) CD4+ T cells: a population of T cells with immune regulatory activities in vitro.

S Read1, S Mauze, C Asseman, A Bean, R Coffman, F Powrie.   

Abstract

An antibody reactive with CD38 revealed both phenotypic and functional heterogeneity amongst CD45RB(low) cells. Functional analysis of the CD38+ and CD38- fractions showed that the latter contained T cells which responded to recall antigens and produced high levels of cytokine in response to polyclonal stimulation. In contrast, the CD38+ population failed to proliferate or to produce detectable levels of cytokines. Despite appearing unresponsive, the CD38+ population significantly inhibited anti-CD3-induced proliferation and cytokine secretion by the reciprocal CD38- population. Immune suppression required stimulation through the TCR and was dependent on a physical interaction between regulatory and responding CD4+ populations. It did not involve killing of the responding T cells or secretion of IL-10 or TGF-beta. Despite some similarities there is no direct correlation between the in vitro suppression characteristic of the CD38+ CD45RB(low) subset and in vivo suppression which has been shown to be mediated by unseparated CD45RB(low) CD4+ T cells. However, these results demonstrate that two functionally distinct subsets of T cells reside within the antigen-exposed or CD45RB(low) CD4+ T cell population and are thus generated in vivo: (1) conventional memory T cells which proliferate and secrete cytokines in response to activation and (2) a population of regulatory T cells which inhibit T cell activation in vitro. Antibodies reactive with CD38 may provide a useful tool with which to study the role of these T cell subsets in the induction and regulation of the immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9842886     DOI: 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.0.CO;2-P

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  48 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Control of immune pathology by IL-10-secreting regulatory T cells.

Authors:  S Fowler; F Powrie
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Impaired gamma interferon responses against parvovirus B19 by recently infected children.

Authors:  A Corcoran; S Doyle; D Waldron; A Nicholson; B P Mahon
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  CD25+CD4+ T cells contribute to the control of memory CD8+ T cells.

Authors:  Masaaki Murakami; Akemi Sakamoto; Jeremy Bender; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

5.  CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism.

Authors:  Zhenhua Dai; Qi Li; Yinong Wang; Ge Gao; Lonnette S Diggs; George Tellides; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

6.  Regulatory T cells and regulation of allergic airway disease.

Authors:  Helen Martin; Christian Taube
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

Review 7.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

9.  Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy.

Authors:  J C Gaardbo; S D Nielsen; S J Vedel; A K Ersbøll; L Harritshøj; L P Ryder; J O Nielsen; L Kolte
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

10.  Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.

Authors:  Aurélie Trenado; Frédéric Charlotte; Sylvain Fisson; Micael Yagello; David Klatzmann; Benoit L Salomon; José L Cohen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.